BTE, a global innovator in objective human performance evaluation and rehabilitation technology, has launched its new Research Services group. For over 35 years, BTE has pioneered evidence-based systems to support quantitative muscle testing (QMT) for employers, physicians and other healthcare providers. In recent months, BTE has expanded into supporting the needs of drug development professionals and research scientists with our knowhow and measurement technologies. The Research Services group leverages the technical expertise and scientific leadership already present in BTE’s Rehabilitation Equipment and Workforce Solutions business units.
“Rising demand for quantitative muscle testing from the pharmaceutical industry and academia has driven us to establish a dedicated Research Services group,” said Charles Wetherington, president of BTE. “Over the years, we’ve had a lot of success in the research space, providing unrivaled objective data collection and reporting solutions for our clients. Now, with the experience of seven global clinical trials in over 20 countries, we have decided the timing is right to formally launch BTE Research Services.”
BTE’s Research Services provides sponsors and clinical scientists with a smarter, more economical alternative to the traditional approach of manual muscle testing. Initial service offerings include fully customized software and equipment, expert training and project management—all proven to support collection of clean, complete and accurate data, consistently from site to site.
“BTE’s turnkey solutions reduce the cost and time associated with collection of muscle strength and endurance data,” said Larry Brownstein, an industry consultant with nearly 20 years’ experience in clinical research. “So much of data collection in clinical research is now done electronically; sponsors are increasingly in need of ways to reduce costs and time associated with pen and paper data collection. The BTE solution is more efficient and more reliable than traditional approaches.”